DNAnexus, Inc.

DNAnexus is the world's most trusted platform for precision health, offering a cloud-based environment where multiomic data and artificial intelligence converge to drive scientific breakthroughs. The platform enables hundreds of biomedical organizations — spanning biopharma, clinical diagnostics, biobanks, academic medical centers, and regulatory bodies — to manage, analyze, and collaborate on multimodal data at scale, ultimately unlocking insights that improve patient care.

At its core, DNAnexus helps precision health innovators break down data silos, generate insights faster using AI, and collaborate with regulatory-grade security. The platform is recognized as a trusted partner by some of the world's leading biomedical institutions, including Regeneron Genetics Center, Natera, and UK Biobank, and has received numerous industry accolades including Frost & Sullivan's 2025 Technology Innovation Leadership Award and a 2025 Prix Galien USA nomination.

Core Platform Capabilities

• Data Management: Provides a single source of truth for multimodal and multiomic data, breaking down organizational silos and enabling unified access across teams.
• AI-Powered Analysis: Leverages artificial intelligence to build cohorts and generate insights faster through an intuitive user interface, reducing time-to-discovery.
• Secure Collaboration: Enables breakthrough science at scale with regulatory-grade security, supporting global teams and sensitive datasets with a robust security model.

Bioinformatics Workflow Tools

• Rapid Workflow Development: Supports multiple workflow languages including Nextflow and WDL, with the ability to integrate custom tools via Docker and instantly reuse pipelines across projects.
• Optimized for Wet and Dry Lab Teams: Bioinformatics developers can leverage a native CLI, while non-technical users benefit from an intuitive graphical interface, streamlining the experience for both audiences.
• Pre-Built Tools and Apps: Offers a library of pre-built tools and applications to accelerate analyses and save time, cutting pipeline deployment time by up to 40% compared to do-it-yourself solutions.

Industry Solutions

• Biopharma: Unlocks the power of multi-omics and clinical data to accelerate target identification, biomarker discovery, and the development of next-generation drugs and treatments.
• Clinical Diagnostics: Helps diagnostic businesses scale to meet volume demand, expand their portfolio of genetic services, and grow their global reach.
• Regulatory Solutions: Transforms global regulatory collaboration and streamlines regulatory workflows through cloud-based solutions purpose-built for life sciences.
• Academic Medical Centers: Enables seamless and secure analysis and delivery of genomic data and results without the need for local compute infrastructure.
• Biobanks & Population Health Programs: Provides trusted, scalable, and high-performance data analysis solutions for exploring complex, population-scale genomic and clinical datasets.

Notable Partnerships and Integrations

• DNAnexus has partnered with Oracle to link genomic data to electronic health records, expanding the utility of precision health data in clinical settings.
• EpiCypher has launched CUTANA® Cloud for CUT&RUN/Tag analysis, powered by the DNAnexus platform, enabling easy epigenomics in the cloud.
• DNAnexus supports ARPA-H initiatives pioneering adaptive cancer treatment approaches.
• The platform hosts the world's largest single-cell dataset, demonstrating its capacity for population-scale data management.
• DNAnexus is collaborating with Myriad Genetics to scale operations and impact patient outcomes.

DNAnexus saves organizations significant time, effort, and cost compared to building and maintaining do-it-yourself solutions, positioning itself as both a technology platform and a long-term expert partner in genomic computing and precision health innovation.